Functional assays (cell counting kit‐8, Transwell migration/invasion assays, apoptosis assays, and tumor sphere formation) demonstrated that both inhibition of NUTM2A‐AS1 and overexpression of miR‐376a‐3p markedly reduced cell proliferation and CSC‐like characteristics [94]. The gene discussed is NUTM2A; the disease is neoplasm.